首页> 外国专利> Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers

Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers

机译:核磷蛋白可预测淋巴样或上皮癌

摘要

A preparation of antibodies which specifically binds to a mammalian protein comprising an amino acid sequence as shown in Figure 9. Also provided is a diagnostic method for predicting malignant potential of lymphoid and epithelial tumors, comprising obtaining a sample from human lymphoid or epithelial tissue and contacting the sample with antibodies which specifically bind a mammalian protein found in the nucleus of A20 cells having a molecular weight of about 35 kDa as determined by SDS-PAGE, wherein said mammalian protein is a substrate for casein kinase II in vitro.
机译:特异性结合包含图9所示氨基酸序列的哺乳动物蛋白的抗体的制备方法。还提供了一种预测淋巴样和上皮肿瘤恶性潜能的诊断方法,包括从人淋巴或上皮组织中获取样品并进行接触通过SDS-PAGE测定,用特异性结合在A20细胞核中发现的哺乳动物蛋白的抗体的样品具有分子量为约35kDa,其中所述哺乳动物蛋白是酪蛋白激酶II的体外底物。

著录项

  • 公开/公告号AU694290B2

    专利类型

  • 公开/公告日1998-07-16

    原文格式PDF

  • 申请/专利权人 THE JOHNS HOPKINS UNIVERSITY;

    申请/专利号AU19950040506

  • 发明设计人 GARY R. PASTERNACK;

    申请日1995-12-18

  • 分类号C07K14/47;C07K16/18;C12N15/12;G01N33/574;

  • 国家 AU

  • 入库时间 2022-08-22 02:52:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号